Purchase Order HT001424P0025
Award Date
12/11/23
Potential Completion Date
12/10/26
Potential Value
$200K
Federal Agency
Defense Health Agency
Awardee
Cepheid
Ultimate Awardee
Not listed
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Naval Academy, MD 21402, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $123,607.98, is for a service agreement (GX16A1Y) with an ultimate completion date of April 12, 2027. Cepheid, which is registered in the System for Award Management (SAM.gov), will provide the DHA with GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to...
The U.S. Department of Defense's Defense Health Agency has awarded a firm-fixed-price purchase order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for services related to Cepheid's GeneXpert DX Systems in the Department of Pathology. The contract, valued at $326,745.25, has an ultimate completion date of September 10, 2025. Cepheid, the prime contractor, is not designated as a set-aside. The company has a history of providing diagnostic testing equipment,...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for a Laboratory Cepheid GeneXpert Service Agreement. The $103,975.00 contract has a period of performance through June 18, 2028 and does not have a set-aside designation. Cepheid has received numerous prime federal contracts to provide diagnostic testing equipment, reagents, consumables, and associated maintenance and support services to...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for a CEPHEID GENEXPERT LABORATORY SYSTEMS SERVICE AGREEMENT AND PREVENTIVE MAINTENANCE contract. The contract has a ceiling value of $78,830.00 and an ultimate completion date of January 31, 2029. The contract does not have a set-aside designation. Cepheid, the prime contractor, specializes in advanced diagnostic systems and test kits for...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for a service agreement to provide GeneXpert diagnostic equipment, reagents, consumables, and associated maintenance and support services. The contract has a ceiling value of $16,492.68 and a performance period ending on July 31, 2024. Cepheid has been awarded numerous prime federal contracts and indefinite-delivery vehicles (IDVs)...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $101,475.00, is for the provision of CEPHEID SERVICE and has an ultimate completion date of July 31, 2028. The contract does not have a set-aside designation. Cepheid, the prime contractor, is an experienced federal contractor, having been awarded numerous prime contracts and subcontracts to provide diagnostic testing...
The Department of Defense (DoD) Defense Health Agency awarded a firm fixed-price purchase order to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, for the provision of two GeneXpert XVI molecular diagnostic systems. The $173,400.00 contract has an ultimate completion date of September 10, 2024 and does not utilize any set-aside designations. Cepheid is an original equipment manufacturer and prime contractor that specializes in advanced diagnostic systems and test...
This is a $494,875.00 firm fixed-price definitive contract awarded by the Defense Health Agency (DHA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for CEPHEID GENX SERVICES, with an ultimate completion date of April 9, 2028. The contract does not have a set-aside designation. Cepheid, the prime contractor, specializes in advanced diagnostic systems and test kits for infectious diseases, genetic conditions, and clinical testing. Under this contract,...
The Defense Health Agency has awarded a firm-fixed-price purchase order to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for a GeneXpert IV Service Agreement plus four option years. The contract, valued at $36,197.21, will provide GeneXpert diagnostic equipment, reagents, consumables, and maintenance services to support clinical testing programs for the agency. Cepheid is the prime contractor and original equipment manufacturer, and the contract does not have a...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $279,558.00 contract is for a GeneXpert service agreement to provide equipment, reagents, test kits, and maintenance services for molecular diagnostic testing capabilities, including for detecting infectious diseases such as COVID-19, influenza, and others. Cepheid holds several significant federal contract Indefinite Delivery Vehicles (IDVs)...